| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.63(B) |
| Last
Volume: |
312,749 |
Avg
Vol: |
474,659 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
13,980 |
32,126 |
49,188 |
92,025 |
| Total Sell Value |
$3,536,285 |
$7,770,851 |
$11,076,421 |
$21,442,724 |
| Total People Sold |
5 |
6 |
6 |
8 |
| Total Sell Transactions |
6 |
11 |
15 |
27 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johst David P |
Corporate Executive VP |
• • – |
2020-02-23 |
4 |
D |
$173.64 |
$149,678 |
D/D |
(862) |
225,358 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2020-02-23 |
4 |
D |
$173.64 |
$9,724 |
D/D |
(56) |
1,992 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$314,983 |
D/D |
(1,814) |
293,250 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$59,732 |
D/D |
(344) |
21,634 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$49,835 |
D/D |
(287) |
18,644 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$53,481 |
D/D |
(308) |
23,406 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$55,044 |
D/D |
(317) |
19,995 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$133,703 |
D/D |
(770) |
226,220 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2020-02-22 |
4 |
D |
$173.64 |
$8,856 |
D/D |
(51) |
2,048 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
295,064 |
|
- |
|
| Milne George M Jr |
Director |
• • – |
2020-02-18 |
4 |
S |
$176.07 |
$1,262,430 |
D/D |
(7,170) |
27,037 |
|
3% |
|
| Milne George M Jr |
Director |
• • – |
2020-02-18 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
34,207 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2020-02-14 |
4 |
S |
$174.29 |
$615,258 |
D/D |
(3,530) |
29,367 |
|
-1% |
|
| Wallman Richard F |
Director |
• • – |
2020-02-14 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
32,897 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2020-02-13 |
4 |
S |
$172.02 |
$1,233,391 |
D/D |
(7,170) |
29,367 |
|
0% |
|
| Wallman Richard F |
Director |
• • – |
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
36,537 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-13 |
4 |
S |
$171.88 |
$2,578,440 |
D/D |
(15,000) |
298,064 |
|
0% |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-13 |
4 |
S |
$172.11 |
$1,187,699 |
D/D |
(6,901) |
18,931 |
|
0% |
|
| Bertolini Robert J |
Director |
• • – |
2020-02-13 |
4 |
S |
$170.41 |
$1,221,819 |
D/D |
(7,170) |
27,875 |
|
0% |
|
| Bertolini Robert J |
Director |
• • – |
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
35,045 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-13 |
4 |
S |
$172.05 |
$154,845 |
D/D |
(900) |
23,714 |
|
0% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-13 |
4 |
S |
$170.29 |
$766,319 |
D/D |
(4,500) |
21,978 |
|
0% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$611,783 |
D/D |
(3,846) |
24,614 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,745 |
28,460 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$800,281 |
D/D |
(5,031) |
26,478 |
|
- |
|
1164 Records found
|
|
Page 19 of 47 |
|
|
0.34 (0.16%) 
